Form 4: Director Leo Furcht Receives Celcuity Equity Grant

Director Leo Furcht acquired 1,530 restricted stock units in Celcuity Inc. as part of a standard equity compensation grant.

Summary

• Director Leo Furcht was granted 1,530 restricted stock units (RSUs) of Celcuity Inc. common stock.
• The transaction occurred on June 5, 2026.
• The RSUs were granted at a price of $0 per share.
• Following this transaction, the director's total beneficial ownership increased to 12,530 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial health.

Positives

• Alignment of director interests with shareholders through equity-based compensation.

Negatives

• None identified.

Risks

• Vesting of the units is contingent upon the 2027 annual meeting of stockholders or April 30, 2027, whichever occurs first.

Future Outlook

The restricted stock units are scheduled to vest on the earlier of the 2027 annual meeting of stockholders or April 30, 2027.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are a standard corporate governance practice in the biotechnology sector to ensure long-term alignment with company performance.

Comparison to Industry Standards

• The grant of restricted stock units to directors is consistent with standard compensation practices for small-cap biotechnology firms.
• The vesting schedule tied to annual meetings is a common industry practice for board members.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity compensation event.

Next Steps

• Vesting of the 1,530 restricted stock units by April 30, 2027, or the 2027 annual meeting.

Key Dates

Keywords

Celcuity, CELC, Form 4, Insider Trading, Equity Compensation, Director Ownership